Biomedicina predictiva e investigación traslacional de las enfermedades respiratorias, cardiovasculares y metabólicas
BIOPRE
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2023
-
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1759-1770.e7
2018
-
Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes
Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567
-
Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice
Archivos de Bronconeumologia, Vol. 54, Núm. 9, pp. 467-475
2017
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265
-
The variability of respiratory symptoms and associated factors in COPD
Respiratory Medicine, Vol. 129, pp. 165-172